An article on Physorg.com reveals the results of a small Phase II HIV vaccine
trial in Tanzania: “An HIV vaccine tested in Tanzania has shown positive results in preliminary trials and may provide better protection than a promising Thai vaccine unveiled on September 24, Swedish researchers said Monday.” (Read the full article here).
One of the reasons for the increased success (up to 50% protection vs. 30% in the Thailand study) is that this vaccine included more strains of the virus. The vaccine was tested in 60 healthy Tanzanian policemen. The results will be presented at an HIV/AIDS vaccine conference in Paris on Wednesday.
So much in the news lately about HIV vaccines, and now Tanzania has been involved as well. We’ll have to watch closely over the next few months to see if this trial moves to Phase III (a larger-scale investigation) or if anything substantial comes out of the Thailand trial.